CLGN NASDAQ
CollPlant Biotechnologies Ltd.
1W: -19.5%
1M: -0.3%
3M: -20.1%
YTD: -76.9%
1Y: -86.5%
3Y: -93.9%
5Y: -97.9%
$3.46
-0.11 (-3.08%)
Weekly Expected Move ±15.0%
$2
$3
$3
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$9M
+33.2% ▲
Capital Expenditures
$28K
+94.2% ▲
5Y CAGR: -42.3%
Free Cash Flow
-$9M
+35.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
+58.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $237K | -$17M | -$7M | -$17M | -$11M |
| Depreciation & Amort. | $773K | $1M | $1M | $1M | $912K |
| Stock-Based Comp. | $2M | $2M | $2M | $2M | $0 |
| Change in Working Capital | $155K | -$611K | $1M | -$262K | $254K |
| Other Non-Cash Items | -$284K | $588K | $216K | $21K | $904K |
| Operating Cash Flow | $3M | -$14M | -$3M | -$14M | -$9M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$1M | -$954K | -$483K | -$28K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $1K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$30M | $30M | -$202K | -$56K | $0 |
| Investing Cash Flow | -$32M | $29M | -$1M | -$539K | -$27K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $39M | $2M | $1M | $9K | $0 |
| Financing Cash Flow | $39M | $2M | $1M | $9K | $3M |
| Net Change in Cash | $10M | $16M | -$3M | -$15M | -$6M |
| Cash End of Period | $13M | $30M | $27M | $12M | $6M |
| Free Cash Flow | $1M | -$15M | -$4M | -$15M | -$9M |